T2 Biosystems, Inc. is an American biotechnology company that specializes in the diagnosis of infectious diseases. It utilizes a technology called T2 Magnetic Resonance (T2MR), which combines magnetic resonance with nanoparticles for the detection of pathogens in biological samples. T2 Biosystems focuses on innovative diagnostic solutions aimed at accelerating the process of infection diagnosis and improving patient care. Shares of T2 Biosystems, Inc. are traded on the stock exchange and may be an interesting investment opportunity for those following developments in biotechnology and diagnostics.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
